Clinical Trial

AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation

Study acronym: AMPER-AF
Recruiting
View on ClinicalTrials.gov →
Summary
A study comparing atrioventricular junction ablation (AVJA) versus continued optimum medical rate control in patients with cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) with suboptimal heart rate control on optimum medication.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-17.
Status change: Not Yet Recruiting → Recruiting 2023-06-07
Trial Details
NCT Number NCT05776797
Lead Sponsor University Hospital Ostrava
Conditions Recurrent Atrial Fibrillation, Persistent Atrial Fibrillation
Enrollment 480 participants
Start Date 2023-04-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-03-31 (estimated)
Updated on ClinicalTrials.gov 2023-06-08